Analysis of Clinical Trial Institutions in Chongqing Area
10.13748/j.cnki.issn1007-7693.20232720
- VernacularTitle:重庆地区临床试验机构现状分析
- Author:
Liya CAO
1
;
Linli XIE
1
;
Jiangchuan XIE
1
;
Xinmei PAN
1
;
Pan MA
1
;
Xin ZHANG
1
;
Yongchuan CHEN
1
Author Information
1. Department of Pharmacy, First Affiliated Hospital of Army Medical University, Chongqing 400038, China
- Publication Type:Journal Article
- Keywords:
clinical trials ；clinical trial institutions ； questionnaire survey
- From:
Chinese Journal of Modern Applied Pharmacy
2024;41(9):1275-1280
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE :To investigate the current situation of clinical trial institutions in Chongqing after the recording system of clinical trial institutions, and to put forward suggestions.
METHODS
A total of 34 clinical trial institutions in Chongqing were selected as the research objects. The research contents mainly included the basic situation of the institutions, staffing, hardware and software construction, project operation and work difficulties, etc. Combined with the research results, suggestions were put forward for the difficulties of the new and old institutions in the operation of clinical trial institutions.
RESULTS
A total of 29 questionnaires were collected and 29 were valid. The release of clinical trial resources in Chongqing were not sufficient and uniform, there were problems such as insufficient incentive policies, lack of information platform construction, and the number and professional degrees of practitioners need to be improved. The new institutions had certain advantages in project load, office space and willingness to undertake, but it was restricted by principle investigator qualification, project experience and institutional reputation.
CONCLUSION
It is suggested to clarify the incentive mechanism, enhance the enthusiasm of clinical trials and establish a standardized training mechanism for clinical trial professionals. Make full use of the information platform to improve the efficiency of clinical trials, build a regional information platform to share information and resources, and accelerate the development of regional clinical trials.
